Login / Signup

High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel Diseases.

Alexa N SassonAshwin N Ananthakrishnan
Published in: Digestive diseases and sciences (2021)
The presence of high titers of anti-drug antibodies to IFX is not predictive of treatment failure with adalimumab.
Keyphrases
  • rheumatoid arthritis
  • emergency department
  • juvenile idiopathic arthritis
  • combination therapy
  • drug induced
  • smoking cessation
  • adverse drug